Vaxcyte, Inc. Common Stock PCVX

$55.39 -5.09% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-11-13 View →
4 FORM 4 2026-11-04 View →
4 FORM 4 2026-11-04 View →
10-Q 10-Q 2026-11-04 View →
8-K 8-K 2026-11-04 View →
8-K 8-K 2026-10-09 View →
424B5 424B5 2026-10-08 View →
424B5 424B5 2026-10-08 View →
4 FORM 4 2026-10-07 View →
4 FORM 4 2026-10-07 View →
424B5 424B5 2026-10-06 View →
424B5 424B5 2026-10-06 View →
8-K 8-K 2026-10-05 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
8-K 8-K 2026-09-03 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-08-05 View →
4 FORM 4 2026-08-05 View →
4 FORM 4 2026-08-05 View →
10-Q 10-Q 2026-08-05 View →
8-K 8-K 2026-08-05 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-16 View →
8-K 8-K 2026-07-15 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-23 View →
8-K 8-K 2026-06-23 View →
4 FORM 4 2026-06-18 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$55.39
Market Cap
$9.24 billion
52-Week Range
$39.87 – $90.75
Average Volume
1.87 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.